Dickie H, Vedio A, Dundas R, Treacher D F, Leach R M
Department of Intensive Care, St Thomas' Hospital, London, UK.
Intensive Care Med. 1998 Oct;24(10):1009-17. doi: 10.1007/s001340050709.
To determine whether the therapeutic intervention scoring system (TISS) reliably reflects the cost of the overall intensive care unit (ICU) population, subgroups of that population and individual ICU patients.
Prospective analysis of individual patient costs and comparison with TISS.
Adult, 12 bedded general medical and surgical ICU in a university teaching hospital.
Two hundred fifty-seven consecutive patients including 52 coronary care (CCU), 99 cardiac surgery (CS) and 106 general ICU (GIC) cases admitted to the ICU during a 12-week period in 1994. A total of 916 TISS-scored patient days were analysed
A variable cost (VC) that included consumables and service usage (nursing, physiotherapy, radiology and pathology staff costs) for individual patients was measured daily. Nursing costs were calculated in proportion to a daily nursing dependency score. A fixed cost (FC) was calculated for each patient to include medical, technical and clerical salary costs, capital equipment depreciation, equipment and central hospital costs. The correlation between cost and TISS was analysed using regression analysis.
For the whole group (n = 257) the average daily FC was pound sterling 255 and daily VC was pound sterling 541 (SEM 10); range pound sterling 23-pound sterling 2,806. In the patient subgroups average daily cost (FC + VC) for CCU was pound sterling 476 (SEM 17.5), for CS pound sterling 766 (SEM 13.8) and for GIC pound sterling 873 (SEM 13.6). In the group as a whole, a strong correlation was demonstrated between VC and the TISS for each patient day (r = 0.87, p < 0.001) and this improved further when the total TISS score was compared with the total VC of the entire patient episode (r = 0.93, p < 0.001). This correlation was maintained in CCU, CS and GIC patient cohorts with only a small median difference between actual and predicted cost (2.2 % for GIC patients). However, in the individual patient, the range of error was up to +/- 65 % of the true variable cost. For the whole group the variable cost per TISS point was pound sterling 25.
These results demonstrate that TISS reliably measures overall ICU population costs as well as those of the subgroups CCU, CS and GIC. However, the relationship between TISS and cost is less reliable for the individual patient.
确定治疗干预评分系统(TISS)能否可靠反映重症监护病房(ICU)全体患者、该群体亚组以及个别ICU患者的费用情况。
对个体患者费用进行前瞻性分析,并与TISS进行比较。
一所大学教学医院的拥有12张床位的成人普通内科和外科ICU。
1994年为期12周期间入住ICU的257例连续患者,包括52例冠心病监护病房(CCU)患者、99例心脏外科(CS)患者和106例普通ICU(GIC)患者。共分析了916个有TISS评分的患者日。
每天测量个体患者的可变成本(VC),包括消耗品和服务使用情况(护理、物理治疗、放射科和病理科工作人员成本)。护理成本根据每日护理依赖评分按比例计算。为每位患者计算固定成本(FC),包括医疗、技术和文书人员工资成本、资本设备折旧、设备和中心医院成本。使用回归分析分析成本与TISS之间的相关性。
对于整个组(n = 257),平均每日FC为255英镑,每日VC为541英镑(标准误10);范围为23英镑至2806英镑。在患者亚组中,CCU的平均每日成本(FC + VC)为476英镑(标准误17.5),CS为766英镑(标准误13.8),GIC为873英镑(标准误13.6)。在整个组中,显示出每个患者日的VC与TISS之间有很强的相关性(r = 0.87,p < 0.001),当将TISS总分与整个患者病程的总VC进行比较时,这种相关性进一步提高(r = 0.93,p < 0.001)。这种相关性在CCU、CS和GIC患者队列中得以维持,实际成本与预测成本之间的中位数差异很小(GIC患者为2.2%)。然而,在个体患者中,误差范围高达真实可变成本的+/- 65%。对于整个组,每个TISS点的可变成本为25英镑。
这些结果表明,TISS能够可靠地衡量ICU全体患者以及CCU、CS和GIC亚组的成本。然而,TISS与成本之间的关系在个体患者中不太可靠。